Format

Send to

Choose Destination
Asian Pac J Cancer Prev. 2014;15(24):10985-9.

DNA ligase4 as a prognostic marker in nasopharyngeal cancer patients treated with radiotherapy.

Author information

1
Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea E-mail : drosy@dau.ac.kr.

Abstract

BACKGROUND:

The capability for DNA double-strand breaks (DSBs) repair is crucial for inherent radiosensitivity of tumor and normal cells. We have investigated the clinicopathologic significance of DNA repair gene expression in nasopharyngeal (NP) carcinoma.

MATERIALS AND METHODS:

A total of 65 NP cancer patients who received radiotherapy were included. The immunopositivity to Ku 70, DNA-PKcs, MRN, RAD50, XRCC4, and LIG4 were examined in all tumor tissues.

RESULTS:

The patients comprised 42 males and 23 females, with a median age of 56 years (range, 18-84). The expression levels of RAD50 (0,+1,+2,+3) were 27.7%, 32.3%, 21.5%, and 18.5%. LIG4 (±) were 43.1% and 56.9% respectively. The 5-year OS rate of patients with LIG4 (±) were 90% and 67.9%, respectively (p=0.035). The 5-year TTP rate of patients with LIG4 (±) were 75.9%, 55.5%, respectively (P=0.039).

CONCLUSIONS:

Our results suggest the possibility of predicting the radiosensitivity of NP cancer by performing immunohistochemical analysis of LIG4.

PMID:
25605214
DOI:
10.7314/apjcp.2014.15.24.10985
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Asian Pacific Organization for Cancer Prevention
Loading ...
Support Center